NCT01330901 Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT01276847 A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206) Status COMPLETED Phase PHASE1
NCT01091051 Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis Status TERMINATED Phase PHASE3
NCT01090063 Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis Status COMPLETED Phase NA
NCT01081730 Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database Status COMPLETED Phase N/A
NCT01081704 A Study of the Pharmacokinetics of Ustekinumab in Chinese Male Subjects Status COMPLETED Phase PHASE1
NCT01059773 A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE4
NCT01008995 A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis Status COMPLETED Phase PHASE3
NCT00955279 A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis Status COMPLETED Phase PHASE2
NCT00320216 A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE2
NCT00267969 A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE3